Maudhoo Ashwini, Maharaj Avinaash, Buonocore Federica, Martos-Moreno Gabriel Angel, Argente Jesús, Achermann John C, Chan Li F, Metherell Lou A
Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, London, UK.
Endocrinol Diabetes Metab Case Rep. 2021 Sep 1;2021. doi: 10.1530/EDM-21-0128.
Congenital isolated ACTH deficiency (IAD) is a rare condition characterised by low plasma ACTH and serum cortisol with normal production of other pituitary hormones. TBX19 (also known as TPIT) is a T-box pituitary restricted transcription factor important for POMC gene transcription and terminal differentiation of POMC-expressing cells. TBX19 gene mutations have been shown to cause neonatal-onset congenital IAD. We report a neonate of Romanian origin, who presented at 15 h of life with respiratory arrest and hypoglycaemia which recurred over the following 2 weeks. Biochemical investigations revealed IAD, with undetectable serum cortisol (cortisol < 1 μg/dL; normal range (NR): 7.8-26.2) and plasma ACTH levels within the normal range (22.1 pg/mL; NR: 4.7-48.8). He responded to hydrocortisone treatment. Patient DNA was analysed by a HaloPlex next-generation sequencing array targeting genes for adrenal insufficiency. A novel homozygous synonymous mutation p.Thr96= (Chr1:168260482; c.288G>A; rs376493164; allele frequency 1 × 10-5, no homozygous) was found in exon 2 of the TBX19 gene. The effect of this was assessed by an in vitro splicing assay, which revealed aberrant splicing of exon 2 giving rise to a mutant mRNA transcript whereas the WT vector spliced exon 2 normally. This was identified as the likely cause of IAD in the patient. The predicted protein product would be non-functional in keeping with the complete loss of cortisol production and early presentation in the patient.
Synonymous variants (a nucleotide change that does not alter protein sequence) usually thought to be benign may still have detrimental effects on RNA and protein function causing disease. Hence, they should not be ignored, especially if very rare in public databases. In vitro splicing assays can be employed to characterise the consequence of intronic and exonic nucleotide gene changes that may alter splicing. Establishing a diagnosis due to a TBX19 mutation is important as it defines a condition of isolated ACTH deficiency not associated with additional pituitary deficiencies.
先天性孤立性促肾上腺皮质激素缺乏症(IAD)是一种罕见病症,其特征为血浆促肾上腺皮质激素(ACTH)水平低、血清皮质醇水平低,而其他垂体激素分泌正常。TBX19(也称为TPIT)是一种T盒垂体限制性转录因子,对阿黑皮素原(POMC)基因转录及表达POMC的细胞的终末分化很重要。已证实TBX19基因突变可导致新生儿期先天性IAD。我们报告了一名罗马尼亚裔新生儿,出生15小时时出现呼吸骤停和低血糖,在接下来的2周内反复出现。生化检查显示为IAD,血清皮质醇检测不到(皮质醇<1μg/dL;正常范围(NR):7.8 - 26.2),血浆ACTH水平在正常范围内(22.1 pg/mL;NR:4.7 - 48.8)。他对氢化可的松治疗有反应。通过针对肾上腺功能不全相关基因的HaloPlex二代测序阵列对患者DNA进行分析。在TBX19基因的第2外显子中发现了一个新的纯合同义突变p.Thr96=(Chr1:168260482;c.288G>A;rs376493164;等位基因频率1×10 - 5,无纯合子)。通过体外剪接试验评估了其影响,结果显示第2外显子出现异常剪接,产生了突变的mRNA转录本,而野生型载体能正常剪接第2外显子。这被确定为该患者IAD的可能病因。预测的蛋白质产物将无功能,这与患者皮质醇分泌完全丧失及早期发病情况相符。
通常认为无害的同义变异(不改变蛋白质序列的核苷酸变化)仍可能对RNA和蛋白质功能产生有害影响,从而导致疾病。因此,不应忽视它们,尤其是在公共数据库中非常罕见的情况下。体外剪接试验可用于表征可能改变剪接的内含子和外显子核苷酸基因变化的后果。确定由TBX19突变引起的诊断很重要,因为它定义了一种孤立性ACTH缺乏症,不伴有其他垂体功能缺陷。